These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23666586)

  • 1. Re: Percutaneous nephrostomy for malignant ureteric obstruction: have we got the balance right?
    Bissada NK; Kamel MH
    Int Urol Nephrol; 2013 Jun; 45(3):633. PubMed ID: 23666586
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right?
    Misra S; Coker C; Richenberg J
    Int Urol Nephrol; 2013 Jun; 45(3):627-32. PubMed ID: 23666587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous nephrostomy in the management of malignant ureteric obstruction.
    Teenan RP; Ramsay A; Deane RF
    Br J Urol; 1989 Sep; 64(3):238-40. PubMed ID: 2804559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of percutaneous nephrostomy in malignant ureteric obstruction.
    Chapman ME; Reid JH
    Br J Radiol; 1991 Apr; 64(760):318-20. PubMed ID: 2025771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous nephrostomy for malignant ureteral obstruction in children. Report of six cases.
    Montagne JP; Couanet D; Geoffray A; Neuenschwander S
    Ann Radiol (Paris); 1986; 29(3-4):401-5. PubMed ID: 3752880
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of ureteric obstruction secondary to malignant pelvic disease.
    Chitale SV; Scott-Barrett S; Ho ET; Burgess NA
    Clin Radiol; 2002 Dec; 57(12):1118-21. PubMed ID: 12475538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-expanding wallstent endoprosthesis for malignant ureteral obstruction.
    Díaz-Lucas EF; Martínez-Torres JL; Fernández Mena J; Carazo Martínez O; de la Fuente Serrano A; Zuluaga Gómez A
    J Endourol; 1997 Dec; 11(6):441-7. PubMed ID: 9440854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonically guided percutaneous nephrostomy.
    Nielsen OS; Grossmann E
    Scand J Urol Nephrol; 1990; 24(3):219-21. PubMed ID: 1700471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
    Bell DG; Fischer MA
    Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: ultrasound guided percutaneous nephrostomy for obstructive uropathy in benign and malignant diseases.
    Rassweiler J
    Int Braz J Urol; 2006; 32(4):470. PubMed ID: 16953918
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications and methods of invasive minimal urinary derivations in oncology].
    Praz V; Chollet Y; Jichlinski P
    Rev Med Suisse; 2007 Dec; 3(136):2788-90, 2792. PubMed ID: 18183814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous nephrostomies.
    Kehinde EO; Newland CJ; Terry TR; Watkin EM; Butt Z
    Br J Urol; 1993 Jun; 71(6):664-6. PubMed ID: 8343890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Outcome of retrograde ureteric stenting as a urinary drainage procedure in ureteric obstruction related to malignant lesions.
    Goonewardena SA; Vickneswaran K
    Ceylon Med J; 2015 Jun; 60(2):75-6. PubMed ID: 26132194
    [No Abstract]   [Full Text] [Related]  

  • 16. Ureteral obstruction and stents: still a difficult problem for patients and urologists alike.
    Russo P
    J Urol; 2005 Dec; 174(6):2088. PubMed ID: 16280733
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nondilated obstructive uropathy: percutaneous nephrostomy performed to reverse renal failure.
    Naidich JB; Rackson ME; Mossey RT; Stein HL
    Radiology; 1986 Sep; 160(3):653-7. PubMed ID: 3526404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Subcutaneous urinary diversions for palliative treatment of pelvic malignancies.
    Irani J; Aubert J
    J Urol; 1996 Sep; 156(3):1137. PubMed ID: 8709328
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of nephrostomy tubes in ureteric obstruction from incurable malignancy.
    Little B; Ho KJ; Gawley S; Young M
    Int J Clin Pract; 2003 Apr; 57(3):180-1. PubMed ID: 12723719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.